ClinicalTrials.govpublic full text
Cixutumumab and Sorafenib Tosylate in Treating Patients With Advanced Liver Cancer
adult hepatocellular carcinoma, advanced adult hepatocellular carcinoma, localized non-resectable adult liver carcinoma, recurrent adult liver carcinoma, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 879875
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.